Heparan sulfate-binding sites on extracellular matrix and associated proteins (HS-binding sites) (HS-binding sites)

Heparan sulfate-binding sites on the extracellular matrix (ECM) and its associated proteins represent a critical regulatory hub for cellular signaling and tissue homeostasis (Vlodavsky et al., 2012, Matrix Biology). These sites, primarily found on heparan sulfate proteoglycans (HSPGs) like perlecan, syndecan, and collagen XVIII, serve as a reservoir for a wide array of heparin-binding growth factors (e.g., VEGF, FGF-2), cytokines, and chemokines (Nader et al., 2004, Biometals). By sequestering these ligands, the ECM protects them from degradation and regulates their spatial distribution and bioavailability. In pathological states such as cancer, these sequestered factors are often released through the action of the enzyme heparanase, promoting tumor angiogenesis, invasion, and metastasis (Hammond et al., 2014, Journal of Medicinal Chemistry). Therapeutic strategies targeting these sites involve the use of heparin mimetics or heparanome modulators that competitively bind to these domains, thereby displacing pro-tumorigenic factors and inhibiting their interaction with signaling receptors (Dredge et al., 2011, Expert Opinion on Investigational Drugs). Additionally, these sites are exploited by various pathogens, including viruses like Herpes Simplex Virus, for initial attachment and entry into host cells (Shukla & Spear, 2001, Journal of Clinical Investigation). Consequently, these targets are of significant interest in oncology and inflammatory disease research for their ability to disrupt the tumor microenvironment and suppress pathological vessel growth.

Other names

Heparan-binding sitesHeparin-binding sitesHSPG-binding domainsECM-sequestration sitesHeparan sulfate-binding motifs

Competitive inhibition of growth factor and cytokine binding to heparan sulfate; displacement of sequestered pro-angiogenic and pro-metastatic factors from the extracellular matrix; inhibition of heparanase-mediated cleavage of heparan sulfate chains.